Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
53.4M
-
Number of holders
-
108
-
Total 13F shares, excl. options
-
41M
-
Shares change
-
+2.76M
-
Total reported value, excl. options
-
$232M
-
Value change
-
+$31.4M
-
Put/Call ratio
-
0.21
-
Number of buys
-
67
-
Number of sells
-
-52
-
Price
-
$5.67
Significant Holders of scPharmaceuticals Inc. - Common Stock (SCPH) as of Q3 2025
141 filings reported holding SCPH - scPharmaceuticals Inc. - Common Stock as of Q3 2025.
scPharmaceuticals Inc. - Common Stock (SCPH) has 108 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 41M shares
of 53.4M outstanding shares and own 76.75% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (6.06M shares), Rubric Capital Management LP (5.1M shares), Weiss Asset Management LP (2.88M shares), BlackRock, Inc. (2.38M shares), VANGUARD GROUP INC (2.18M shares), TUDOR INVESTMENT CORP ET AL (2.15M shares), KING LUTHER CAPITAL MANAGEMENT CORP (2.13M shares), HSBC HOLDINGS PLC (1.9M shares), MORGAN STANLEY (1.67M shares), and GLAZER CAPITAL, LLC (1.38M shares).
This table shows the top 108 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.